Lung Cancers Completed Phase 2 Trials for Gemcitabine (DB00441)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00407550Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00016367Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT01443078Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)Treatment
NCT01781988Personalized Therapy in Non-small Cell Lung CancerTreatment
NCT00970684Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTreatment
NCT00456261First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLCTreatment
NCT00453167Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung CancerTreatment
NCT00413283Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)Supportive Care
NCT00278460Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00276588Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00283244Gemcitabine and/or Erlotinib as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00305786Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00323869Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung CancerTreatment
NCT00193323Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly PatientsTreatment
NCT00182806Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00193453Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung CancerTreatment
NCT00193427Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Patients With Non-Small Cell Lung CancerTreatment
NCT00193414Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00217698Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00103051Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung CancerTreatment
NCT000774153-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerTreatment
NCT000640643-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung CancerTreatment
NCT00070486Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00057798Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryTreatment
NCT00041314Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00033553Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerTreatment
NCT00030433S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00022646Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerTreatment
NCT00005972Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung CancerTreatment
NCT00005850Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTreatment
NCT00006004Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung CancerTreatment
NCT00004139Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00003762Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00004201Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerTreatment
NCT00003587S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00226577Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.Treatment
NCT00326599Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00226590Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLCTreatment